- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/117 - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
Patent holdings for IPC class C12N 15/117
Total number of patents in this class: 751
10-year publication summary
|
58
|
71
|
71
|
71
|
52
|
79
|
65
|
67
|
57
|
19
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Index Pharmaceuticals AB | 49 |
18 |
| AIM ImmunoTech Inc. | 51 |
18 |
| The Trustees of the University of Pennsylvania | 4308 |
17 |
| Dynavax Technologies Corporation | 116 |
14 |
| Idera Pharmaceuticals, Inc. | 82 |
14 |
| Northwestern University | 3364 |
13 |
| Targimmune Therapeutics AG | 35 |
13 |
| Tallac Therapeutics, Inc. | 23 |
13 |
| President and Fellows of Harvard College | 5949 |
12 |
| Rheinische Friedrich-Wilhelms-Universität Bonn | 202 |
12 |
| Curevac SE | 262 |
12 |
| The Regents of the University of California | 19812 |
11 |
| Glaxosmithkline Biologicals S.A. | 1636 |
10 |
| Arizona Board of Regents on behalf of Arizona State University | 2580 |
10 |
| City of Hope | 979 |
10 |
| Modernatx, Inc. | 1260 |
10 |
| Gilead Sciences, Inc. | 2028 |
9 |
| The Board of Trustees of the Leland Stanford Junior University | 6365 |
8 |
| Mayo Foundation for Medical Education and Research | 3188 |
8 |
| Daiichi Sankyo Company, Limited | 1852 |
8 |
| Other owners | 511 |